Pramodini Medicare IPO
Pramodini Medicare IPO is an SME IPO raising ₹69 Cr at ₹110 – ₹118 a share. It listed on 19 Aug 2026 at ₹120, +1.7% against its issue price of ₹118, and trades at ₹127 today (+7.8% since issue). It was subscribed 4.60× in total.
4.6 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
Where your money goes
Only the fresh issue reaches the company. The offer for sale is existing shareholders selling their own stock — that money goes to them, not the business.
A red herring prospectus is filed before the price is fixed, so it states share counts rather than rupee amounts. derived: shares x cut-off price Rs118. Checked: exchange issue size Rs69 Cr vs derived Rs69 Cr (0.0% apart).
What the fresh money funds
The stated uses of the net proceeds, from the prospectus’s Objects of the Issue table. Only the fresh issue funds these — the offer-for-sale money goes to the selling shareholders above.
As stated in the prospectus. “General corporate purposes” is the part with no committed use; SEBI caps it at 25% of the issue.
The price they’re asking
From the prospectus’s own “Basis for Issue Price” — the issuer’s earnings multiple against the peers it chose to compare itself with.
Priced 17% below the median multiple of the peers the issuer itself names.
| Listed peer (issuer’s choice) | P/E | RoNW | EPS |
|---|---|---|---|
| Invicta Diagnostic Limited | 13.62× | 9.76% | ₹4.9 |
| Krsnaa Diagnostics Limited | 16.74× | 10.35% | ₹31.3 |
| Star Imaging & Path Labs Limited | 7.87× | 16.58% | ₹11.05 |
| This issue | 11.3× | 32.69% | ₹10.41 |
derived: cut-off price Rs118 / stated EPS Rs10.41 (FY26 (year ended March 31, 2026) Basic & Diluted EPS, restated consolidated, computed as per AS 20). Peer figures are as printed in the prospectus — they date from its filing, not today. A multiple is one lens, not a verdict.
Terms of the issue
The mechanics of what is being sold. Held for every issue we track.
Not here yet
The anchor-investor allocation — which institutions were allotted shares before bidding opened — is still to be read out of its document.